Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bilsland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|January 17, 2003
Caspases and neuroprotectionJames Bilsland, Sarah Harper
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neuronsJames Bilsland, Sophie Roy, Steve Xanthoudakis, et al.
Nature Biotechnology|July 4, 2012
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptorsStuart M Chambers, Yuchen Qi, Yvonne Mica, et al.
Pain|July 26, 2016
Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locusAmy V Jones, James R F Hockley, Craig Hyde, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
Science Translational Medicine|April 22, 2016
Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgiaLishuang Cao, Aoibhinn McDonnell, Anja Nitzsche, et al.
Journal of Medicinal Chemistry|June 27, 2018
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of PainSharan K Bagal, Mark Andrews, Bruce M Bechle, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|January 17, 2003
Caspases and neuroprotectionJames Bilsland, Sarah Harper
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neuronsJames Bilsland, Sophie Roy, Steve Xanthoudakis, et al.
Nature Biotechnology|July 4, 2012
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptorsStuart M Chambers, Yuchen Qi, Yvonne Mica, et al.
Pain|July 26, 2016
Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locusAmy V Jones, James R F Hockley, Craig Hyde, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
Science Translational Medicine|April 22, 2016
Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgiaLishuang Cao, Aoibhinn McDonnell, Anja Nitzsche, et al.
Journal of Medicinal Chemistry|June 27, 2018
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of PainSharan K Bagal, Mark Andrews, Bruce M Bechle, et al.
Pageof 1